Back to Directory

Acionna Therapeutics

United Kingdom
Founded 2025
Neuroimmune therapeutics for Alzheimer’s disease

Acionna Therapeutics is a biotechnology company developing medicines that target neuroimmune processes involved in Alzheimer’s disease and other central nervous system disorders. Its approach aims to improve synaptic function by intervening in the neuroimmune cascade. The company builds on research from the University of Oxford and Cardiff University, supported by Alzheimer’s Research UK and the UK Dementia Research Institute, and is backed by Oxford Science Enterprises.